Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 0.56 Delayed Data As of 6:30pm ET |  -0.005 / -0.88%Today’s Change | 0.47 Today|||52-Week Range 1.14 | -37.79% Year-to-Date |
| Previous close | 0.56 |
| Today’s open | 0.57 |
| Day’s range | 0.56 - 0.59 |
| Volume | 203,446 |
| Average volume (3 months) | 437,255 |
| Market cap | $38.6M |
| Dividend yield | -- |
| Earnings growth (last year) | +41.94% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.85 |
| Today’s change | Today’s % change | |
|---|---|---|
| OREXOrexigen Therapeutic... | -0.03 | -1.18% |
| EBIOEleven Biotherapeuti... | -0.04 | -2.86% |
| MBRXMoleculin Biotech In... | +0.18 | +8.26% |
| OHRPOHR Pharmaceutical I... | -0.03 | -4.41% |
| Last reporting date | February 25, 2015 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$19.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Financial Officer & Controller Thomas E. Chilcott |
Corporate headquarters Englewood, Colorado |
